These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10981205)

  • 1. Measuring the impact of onychomycosis on patient quality of life.
    Turner RR; Testa MA
    Qual Life Res; 2000 Feb; 9(1):39-53. PubMed ID: 10981205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A health-related quality of life measure for use in patients with onychomycosis: a validation study.
    Lubeck DP; Gause D; Schein JR; Prebil LE; Potter LP
    Qual Life Res; 1999; 8(1-2):121-9. PubMed ID: 10457745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onychomycosis: health-related quality of life considerations.
    Shaw JW; Joish VN; Coons SJ
    Pharmacoeconomics; 2002; 20(1):23-36. PubMed ID: 11817990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.
    Drake LA; Patrick DL; Fleckman P; Andr J; Baran R; Haneke E; Sapède C; Tosti A
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):189-96. PubMed ID: 10426887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of toenail onychomycosis on patient quality of life.
    Elewski BE
    Int J Dermatol; 1997 Oct; 36(10):754-6. PubMed ID: 9372349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life of persons with onychomycosis.
    Lubeck DP; Patrick DL; McNulty P; Fifer SK; Birnbaum J
    Qual Life Res; 1993 Oct; 2(5):341-8. PubMed ID: 8136799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States.
    Peipert JD; Bentler PM; Klicko K; Hays RD
    Am J Kidney Dis; 2018 Apr; 71(4):461-468. PubMed ID: 29128411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring health-related quality of life in onychomycosis.
    Lubeck DP
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S64-8. PubMed ID: 9594940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of onychomycosis on quality of life.
    Drake LA; Scher RK; Smith EB; Faich GA; Smith SL; Hong JJ; Stiller MJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):702-4. PubMed ID: 9591814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a disease-specific quality of life questionnaire (EQOL) for potentially curable patients with carcinoma of the esophagus.
    Clifton JC; Finley RJ; Gelfand G; Graham AJ; Inculet R; Malthaner R; Tan L; Lim J; Singer J; Lovato C
    Dis Esophagus; 2007; 20(3):191-201. PubMed ID: 17509114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naildex: pilot evaluation of an onychodystrophy severity instrument.
    Warshaw EM; Traywick CA; Hoffman AA; Lilly KK; Koshnick RL; Robinson JW; Suwattee P; Foster JK; Chen SC
    Mycoses; 2008 Jan; 51(1):14-20. PubMed ID: 18076590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A health related quality of life measure for use in patients with urge urinary incontinence: a validation study.
    Lubeck DP; Prebil LA; Peeples P; Brown JS
    Qual Life Res; 1999 Jun; 8(4):337-44. PubMed ID: 10472166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of onychomycosis on quality of life.
    Whittam LR; Hay RJ
    Clin Exp Dermatol; 1997 Mar; 22(2):87-9. PubMed ID: 9330072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.